Clinics Delivery across UAE
IV Therapy

Who benefits from IV therapy, and who should wait

A concise clinical guide: the patients who may benefit, the red flags that mean delay, and why we won't book a drip without screening.

Back to journal
BioBlend EditorialClinical review: BioBlend Pharmacy TeamReviewed: 2026-07-21
Who benefits from IV therapy, and who should wait
IV Therapy

Selected groups may benefit from medically supervised IV therapy: patients with documented deficiency who cannot absorb oral nutrients, post-operative hydration needs under guidance, specific chemotherapy supportive care protocols, and defined dermatological or medical infusion treatments.

Equally important is who should not receive a drip today. Pregnancy, kidney or heart impairment, uncontrolled hypertension, history of allergic reaction to infusion components, and active dehydration from vomiting or diarrhoea may all defer or alter the plan. These are not bureaucratic hurdles — they are the basis of safe care.

Our pre-treatment questionnaire, recent blood review and clinician sign-off exist to make sure your treatment matches your physiology. If you are not a candidate today, we will tell you, and explain what would change that.

References

  • 1.American Society for Parenteral and Enteral Nutrition (ASPEN) — clinical guidelines.
  • 2.National Institute for Health and Care Excellence (NICE) — intravenous fluid therapy in adults.
  • 3.Cleveland Clinic — IV vitamin therapy review.
  • 4.UAE Ministry of Health and Prevention — clinical safety standards.